Drug Report History
Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.
The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.
| Version v7-FR | Version v3-EN | |
|---|---|---|
| Language | French | English |
| Date Updated | 2017-05-17 | 2017-04-03 |
| Drug Identification Number | 02375516 | 02375516 |
| Brand name | ZOSTAVAX II | ZOSTAVAX II |
| Common or Proper name | (zoster vaccine live, attenuated [Oka/Merck], refrigerator-stable) powder for suspension for injection | (zoster vaccine live, attenuated [Oka/Merck], refrigerator-stable) powder for suspension for injection |
| Company Name | MERCK CANADA INC | MERCK CANADA INC |
| Ingredients | VARICELLA-ZOSTER VIRUS VACCINE LIVE ATTENUATED | VARICELLA-ZOSTER VIRUS VACCINE LIVE ATTENUATED |
| Strength(s) | 19400PFU | 19400PFU |
| Dosage form(s) | POWDER FOR SUSPENSION | POWDER FOR SUSPENSION |
| Route of administration | SUBCUTANEOUS | SUBCUTANEOUS |
| Packaging size | 1 Dose Vial | 1 Dose Vial |
| ATC code | J07BK | J07BK |
| ATC description | VIRAL VACCINES | VIRAL VACCINES |
| Reason for shortage | Demand increase for the drug. | Demand increase for the drug. |
| Anticipated start date | 2017-05-25 | 2017-05-25 |
| Actual start date | ||
| Estimated end date | 2017-06-16 | 2017-06-12 |
| Actual end date | 2017-05-17 | |
| Shortage status | Avoided shortage | Anticipated shortage |
| Tier 3 Status | No | No |
| Company comments | Shortage Avoided | |
| Health Canada comments |